| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/22/2001 | EP1124958A2 Corticosteroid synthesis-associated genes |
| 08/22/2001 | EP1124957A1 Pholasin |
| 08/22/2001 | EP1124956A2 Pharmaceutical composition, containing fragments of an antigenic protein encoding dna endowed with anti-tumor effect |
| 08/22/2001 | EP1124951A2 Human sorting nexins |
| 08/22/2001 | EP1124950A2 p53 ANTISENSE AGENT AND METHOD |
| 08/22/2001 | EP1124852A1 Lysine-rich statherin protein |
| 08/22/2001 | EP1124850A1 12 human secreted proteins |
| 08/22/2001 | EP1124848A2 Transmembrane 4 proteins |
| 08/22/2001 | EP1124846A2 Nucleotide and protein sequences of nogo genes and methods based thereon |
| 08/22/2001 | EP1124840A1 Ovary-specific genes and proteins |
| 08/22/2001 | EP1124824A1 Chromenone and chromanone derivatives as integrin inhibitors |
| 08/22/2001 | EP1124820A1 Lipoic acid derivatives and their use in treatment of disease |
| 08/22/2001 | EP1124815A1 Method for producing luteolin and luteolin derivatives |
| 08/22/2001 | EP1124811A1 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 08/22/2001 | EP1124810A1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 08/22/2001 | EP1124809A1 Benzoylpyridazines |
| 08/22/2001 | EP1124804A1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors |
| 08/22/2001 | EP1124797A1 N-arylsulfonyl amino acid omega amides |
| 08/22/2001 | EP1124795A1 Inhibitors of the egf-receptor tyrosine kinase and their use |
| 08/22/2001 | EP1124788A2 Bis(haloethyl)aminobenzene derivatives |
| 08/22/2001 | EP1124779A1 Vitamin d analogues |
| 08/22/2001 | EP1124594A1 Implant with cavities containing therapeutic agents |
| 08/22/2001 | EP1124580A1 Enhanced radiation therapy |
| 08/22/2001 | EP1124577A1 USE OF AN ENTEROBACTERIUM PROTEIN OmpA FOR SPECIFIC TARGETING TOWARDS ANTIGEN-PRESENTING CELLS |
| 08/22/2001 | EP1124570A2 Novel neuropilin/growth factor binding and uses thereof |
| 08/22/2001 | EP1124568A1 Polyspecific binding molecules and uses thereof |
| 08/22/2001 | EP1124562A1 Combination therapy to treat hepatitis b virus |
| 08/22/2001 | EP1124557A2 Pharmaceutical composition |
| 08/22/2001 | EP1124553A1 New use of glutamate antagonists for the treatment of cancer |
| 08/22/2001 | EP1124552A1 Antitumor chrysene derivatives |
| 08/22/2001 | EP1124550A1 Methods and compositions for selective cancer chemotherapy |
| 08/22/2001 | EP1124549A1 Water-miscible pharmaceutical compositions of paclitaxel |
| 08/22/2001 | EP1105518A4 USE OF mCRP FOR DELIVERY OF MATERIALS INTO CELLS |
| 08/22/2001 | EP1085811A4 Broad specificity dna damage endonuclease |
| 08/22/2001 | EP0799210B1 Piperazine-2,5-dione derivatives as modulators of multidrug resistance |
| 08/22/2001 | EP0697880B1 Inhibition of leukocyte adhesion |
| 08/22/2001 | EP0673255B1 Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof |
| 08/22/2001 | CN1309710A Genomic sequences upstream of coding region of IFN-alpha 2 gene for protein production and delivery |
| 08/22/2001 | CN1309705A IL-2 selective agonists and antagonists |
| 08/22/2001 | CN1309666A Polymer composition of glucuronic acid glucosan |
| 08/22/2001 | CN1309663A Anti-angiogenic proteins and methods of use thereof |
| 08/22/2001 | CN1309660A Phosphinous and phosphonic acid derivs. used as medicaments |
| 08/22/2001 | CN1309657A Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of growth hormone release inhibiting factor receptors |
| 08/22/2001 | CN1309654A Biphenyl derivs. |
| 08/22/2001 | CN1309639A Pharmaceutical compositions comprising 2-quinolones |
| 08/22/2001 | CN1309634A Hydrazine derivs. |
| 08/22/2001 | CN1309633A Diacylhydrazine derivs. as integrain inhibitors |
| 08/22/2001 | CN1309569A Composition comprising tumor cells and extracts and method for using thereof |
| 08/22/2001 | CN1309563A Use of 1-(aminoalkyl)-3-quinoxaline-2-one derives for preparation of compounds having antioxidant action |
| 08/22/2001 | CN1309176A Separated strain of Antrodia camphorate, process for preparing its culture medium and its product |
| 08/22/2001 | CN1309125A Composition of gambogic acid compounds with anticancer activity and its preparing process |
| 08/22/2001 | CN1308966A Antitumor cell-protein preparation |
| 08/22/2001 | CN1308963A Anticancer medicine powder |
| 08/22/2001 | CN1069829C Percutaneous applied medicine contg. gestodene |
| 08/21/2001 | US6277987 Sulfonylamino acid and sulfonylamino hydroxamic acid derivatives |
| 08/21/2001 | US6277980 Mixed backbone oligonucleotide analog having nucleotide sequence complementary to e6/e7 genes; has phosphorothioate bonds and at least one other phosphorus linking group or modification; viricides |
| 08/21/2001 | US6277977 cDNA clone HAPOI67 that encodes a human 7-transmembrane receptor |
| 08/21/2001 | US6277975 Fusions of P-selectin ligand protein and polynucleotides encoding same |
| 08/21/2001 | US6277972 BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells |
| 08/21/2001 | US6277960 Amino acid sequence of g protein coupled receptor; treatment of eating disorders, asthma, parkinson's disease, cardiovascular and nervous system disorders, huntington's disease, tourett's syndrome, and others; diagnosis |
| 08/21/2001 | US6277880 Chemical compounds |
| 08/21/2001 | US6277876 Antiinflammatory agents; prevent tissue degradation |
| 08/21/2001 | US6277852 Piperazinyl 5-HT1 agonists and antagonists |
| 08/21/2001 | US6277841 Quinoline ligands and metal complexes for diagnosis and therapy |
| 08/21/2001 | US6277839 Antiinflammatory agents, antipyretics, analgesics; side effect reduction |
| 08/21/2001 | US6277837 Treatment of psoriasis, leukemia, cancers, osteoporosis |
| 08/21/2001 | US6277835 Method of tumor treatment |
| 08/21/2001 | US6277824 Enhancing or inhibiting cadherin-mediated functions comprising a his-ala-val sequence binding motif, an peptidomimetic or an antibody that binds to such a motif |
| 08/21/2001 | US6277821 For treating gramnegative and mycobacterium infections; endotoxin and heparin neutralization |
| 08/21/2001 | US6277818 Cyclic peptide ligands that target urokinase plasminogen activator receptor |
| 08/21/2001 | US6277613 TRF1 binding protein, methods of use thereof |
| 08/21/2001 | US6277599 Monoclonal antiboby for the preferential killing of tumors; for diagnosis of cancer; for the treatment of cancer |
| 08/21/2001 | US6277575 Process aimed at evidencing the state of a malignant cell |
| 08/21/2001 | US6277574 Genes associated with diseases of the kidney |
| 08/21/2001 | US6277572 Human NADH dehydrogenase subunits |
| 08/21/2001 | US6277418 Corn extract contraceptive |
| 08/21/2001 | US6277412 A core and an enteric coating, the core including, as a pharmaceutical active compound, 5-aminosalicylic acid homogeneously dispersed in a non gel-forming polymer matrix which extends through the entire core |
| 08/21/2001 | US6277411 Pharmaceutical formulation containing DFMO for the treatment of cancer |
| 08/21/2001 | US6277373 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase |
| 08/21/2001 | US6277368 Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokine |
| 08/21/2001 | US6277357 Ketotricyclo[5.2.1.0]decane derivatives |
| 08/21/2001 | US6277356 Somatostatin peptides, use as a radiopharmaceutical, e.g. for radiotherapy of somatostatin receptor tumors, complexed with y90 |
| 08/21/2001 | US6277061 Method of inhibiting membrane-type matrix metalloproteinase |
| 08/21/2001 | CA2319308C Pharmaceutical agents |
| 08/21/2001 | CA2207348C Benzimidazole derivatives |
| 08/21/2001 | CA2205555C Use of nitric oxide-releasing agents for reducing metastasis risk |
| 08/21/2001 | CA2174315C Oligonucleotide modulation of multidrug resistance-associated protein |
| 08/21/2001 | CA2039855C Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases |
| 08/21/2001 | CA2018751C Stable freeze dried polyhematoporphyrin ether/ester composition |
| 08/21/2001 | CA2012955C Antitumor substance be-13793c |
| 08/16/2001 | WO2001059137A1 Method for remodelling cell wall polysaccharide structures in plants |
| 08/16/2001 | WO2001059133A1 Larynx carcinoma-associated protein larcap-1 |
| 08/16/2001 | WO2001059130A2 Proteins producing an altered immunogenic response and methods of making and using the same |
| 08/16/2001 | WO2001059129A2 Mammalian secreted group iii phospholipase a2 |
| 08/16/2001 | WO2001059127A2 Drug metabolizing enzymes |
| 08/16/2001 | WO2001059120A2 Il-17 like molecules and uses thereof |
| 08/16/2001 | WO2001059115A2 83p5g4: a tissue specific protein highly expressed in prostate cancer |
| 08/16/2001 | WO2001059106A1 Novel g protein-coupled receptor proteins and dnas thereof |
| 08/16/2001 | WO2001059103A2 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression |
| 08/16/2001 | WO2001059073A2 Cytotoxic t lymphocytes activated by dendritic cell hybrids |